CROI 2017 Program and Information

Program and Agenda

Symposium S-9 MODERN ART Room 6 E 4:00 PM - 6:00 PM Target Audience: This session is directed to clinicians and scientists who are interested in understanding contemporary antiretroviral therapy and HIV drug resistance Level of Knowledge: It is assumed that the participants are familiar with the principles of HIV drug resistance and antiretroviral therapy Objectives: At the completion of the session, participants will be able to: • Describe trends in transmitted HIV drug resistance and resistance emergence on ART • Compare strategies for simplification of antiretroviral therapy in patients suppressed on therapy • Summarize the challenges in developing an initial antiretroviral regimen for the global HIV epidemic Conveners Ying-Ru Lo , World Health Organization, Geneva, Switzerland Paul E. Sax , Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA 0146 HIV-1 DRUG RESISTANCE IN RESOURCE-LIMITED SETTINGS Ravindra K. Gupta , Univ College London, London, UK 4:00

Oral Sessions • Thursday

0147 LONG-ACTING ANTIRETROVIRAL THERAPY: A SHOT IN THE DARK OR A PARADIGMSHIFT? Charles W. Flexner , The Johns Hopkins Univ, Baltimore, MD, USA 148 SIMPLE ART: MORE COMPLEX THAN THOUGHT Jose R. Arribas , Hospital La Paz, Madrid, Spain 4:30 5:00

149 TOWARD AN IDEAL ANTIRETROVIRAL REGIMEN FOR THE GLOBAL EPIDEMIC Beatriz Grinsztejn , Oswaldo Cruz Foundation - Fiocruz, Rio de Janeiro, Brazil 5:30

CROI 2017 71